De pancreas
Van conceptie tot levenseinde

De pancreas of alvleesklier is een wat ‘geheimzinnig’ klein orgaan dat verdoken ligt achterin de buikholte. We weten dat hij insuline aanmaakt, en nog een paar andere dingen … Maar verder?
Weinigen realiseren zich hoe belangrijk deze is voor de fysiologie en voor het leven: een goed functionerende pancreas is cruciaal voor optimale gezondheid en longevity.

Beste bezoeker, u heeft geen toegang.

Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.

U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!

Auteur

Marleen Nys

Trefwoorden:

Figuren

Verschenen in

Referenties

  1. Lillycrop KA, Burdge GC. Epigenetic mechanisms linking early nutrition to long term health. Best Pract Res Clin Endocrinol Metab. 2012 Oct;26(5):667-76.

  2. Yajnik CS et al. Neonatal anthropometry: the thin-fat Indian baby. The Pune Maternal Nutrition Study. Int J Obes Relat Metab Disord. 2003 Feb;27(2):173-80.

  3. Kulkarni ML, Mythri HP, Kulkarni AM. 'Thinfat' phenotype in newborns. Indian J Pediatr. 2009 Apr;76(4):369-73.

  4. van Steijn L et al. Neonatal anthropometry: thin-fat phenotype in fourth to fifth generation South Asian neonates in Surinam. Int J Obes (Lond). 2009 Nov;33(11):1326-9.

  5. Frantz ED, Peixoto-Silva N, Pinheiro-Mulder A. Endocrine pancreas development: effects of metabolic and intergenerational programming caused by a protein-restricted diet. Pancreas. 2012 Jan;41(1):1-9.

  6. Martin-Gronert MS, Ozanne SE. Metabolic programming of insulin action and secretion. Diabetes Obes Metab. 2012;14 S 3:29-39.

  7. Lillycrop KA, Burdge GC. Epigenetic changes in early life and future risk of obesity. Int J Obes (Lond). 2011 Jan;35(1):72-83.

  8. Sebert S, Sharkey D, Budge H, Symonds ME. The early programming of metabolic health: is epigenetic setting the missing link? Am J Clin Nutr. 2011 Dec;94(6 Suppl):1953S-1958S.

  9. Theys N, Ahn MT, Bouckenooghe T, Reusens B, Remacle C. Maternal malnutrition programs pancreatic islet mitochondrial dysfunction in the adult offspring. J Nutr Biochem. 2011; 22(10):985-94.

  10. Burdge GC et al. Epigenetic regulation of transcription: a mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life? Br J Nutr. 2007 Jun;97(6):1036-46.

  11. Preidis GA et al. The Undernourished Neonatal Mouse Metabolome Reveals Evidence of Liver and Biliary Dysfunction, Inflammation, and Oxidative Stress. J. Nutr. March 1, 2013 jn.113.183731

  12. Tarry-Adkins JL, Chen JH, Jones RH, Smith NH, Ozanne SE. Poor maternal nutrition leads to alterations in oxidative stress, antioxidant defense capacity, and markers of fibrosis in rat islets: potential underlying mechanisms for development of the diabetic phenotype in later life. FASEB J. 2010; 24(8):2762-71.

  13. Theys N, Bouckenooghe T, Ahn MT, Remacle C, Reusens B. Maternal low-protein diet alters pancreatic islet mitochondrial function in a sex-specific manner in the adult rat. Am J Physiol Regul Integr Comp Physiol. 2009; 297(5):R1516-25.

  14. Chamson-Reig A, Thyssen SM, Arany E, Hill DJ. Altered pancreatic morphology in the offspring of pregnant rats given reduced dietary protein is time and gender specific. J Endocrinol. 2006 Oct;191(1):83-92.

  15. Fowden AL, Hill DJ. Intra-uterine programming of the endocrine pancreas. Br Med Bull. 2001;60:123-42.

  16. Heywood WE, Mian N, Milla PJ, Lindley KJ. Programming of defective rat pancreatic beta-cell function in offspring from mothers fed a low-protein diet during gestation and the suckling periods. Clin Sci (Lond). 2004 Jul;107(1):37-45.

  17. Nys M. Spijsverteringsenzymen, miskend en onderschat, maar essentieel voor gezondheid en leven. AT&A 2012; 5:18-23.

  18. Nys M. Probiotica en de darm: nieuwe gezichtspunten. AT&A 2011; 4:50-52.

  19. Araújo TG et al. Hepatocyte growth factor plays a key role in insulin resistance-associated compensatory mechanisms. Endocrinology. 2012 Dec;153(12):5760-9.

  20. Mellado-Gil J et al. Disruption of hepatocyte growth factor/c-Met signaling enhances pancreatic beta-cell death and accelerates the onset of diabetes. Diabetes. 2011 Feb;60(2):525-36.

  21. Pruimboom L. De lever/pancreas/resistenties binnen de klinische PNI. 2e jaar kPNI. 2011.

  22. de Graaf-Roelfsema E. Glucose homeostasis and the enteroinsular axis in the horse: A possible role in equine metabolic syndrome. Vet J. 2013 Oct 4. pii: S1090-0233(13)00506-6.

  23. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005 Sep;39(8):709-16.

  24. Shachar E, Scapa E. Drug-induced pancreatitis. Harefuah. 2009 Feb;148(2):98-100, 139.

  25. Douros A et al. Drug-induced acute pancreatitis: results from the hospitalbased Berlin case–control surveillance study of 102 cases. Aliment Pharmacol Ther 2013; 38: 825–834

  26. Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007 Jun;5(6):648-61; quiz 644.

  27. Vinklerová I, Procházka M, Procházka V, Urbánek K. Incidence, severity, and etiology of drug-induced acute pancreatitis. Dig Dis Sci. 2010 Oct;55(10):2977-81.

  28. Bromer MQ, Black M. Acetaminophen hepatotoxicity. Clin Liver Dis. 2003 May;7(2):351-67.

  29. Igarashi H, Ito T, Yoshinaga M, Oono T, Sakai H, Takayanagi R. Acetaminophen-induced acute pancreatitis. A case report. JOP. 2009 Sep 4;10(5):550-3.

  30. Koulouris Z, Tierney MG, Jones G. Metabolic acidosis and coma following a severe acetaminophen overdose. Ann Pharmacother. 1999 Nov;33(11):1191-4.

  31. Lochan R, Charnley RM, French JJ, Al-Mukhtar A, Hudson M, Manas DM, White SA. Successful management of necrotizing pancreatitis by percutaneous necrosectomy after orthotopic liver transplant for paracetamol induced acute liver failure: a case report. Exp Clin Transplant. 2009 Jun;7(2):110-4. Review.

  32. Mietka-Ciszowska A, Stojakowska M, Groszek B. Severe paracetamol poisoning complicated with liver and renal failure--case report and review of literature. Przegl Lek. 2012;69(8):614-7.

  33. Hodgman MJ, Garrard AR. A review of acetaminophen poisoning. Crit Care Clin. 2012 Oct;28(4):499-516.

  34. Belhassen García M et al. Pancreatitis due to acetaminophen-codeine. An Med Interna. 2006 Aug;23(8):400-1.

  35. Locher C, Lambare B, Fischer D, Labayle D. Acute pancreatitis induced by codeine-acetaminophen association: report of two cases. Gastroenterol Clin Biol. 2003 Jan;27(1):124-5.

  36. Lederman JC, Nawaz H. Toxic interaction of didanosine and acetaminophen leading to severe hepatitis and pancreatitis: a case report and review of the literature. Am J Gastroenterol. 2001 Dec;96(12):3474-5.

  37. Mogelijk verhoogd risico van pancreatitis en pancreaskanker door de antidiabetische geneesmiddelen die het incretine-effect versterken. http://www.bcfi.be/folia/index.cfm?FoliaWelk=F40N09F

  38. Cohen D. Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed? BMJ 2013;346:f3680

  39. Potential harms of type 2 diabetes drugs have been ignored, finds BMJ investigation. BMJ 2013;346:f3782

  40. Singh S et al. Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes MellitusA Population-Based Matched Case-Control Study. JAMA Intern Med. 2013;173(7):534-539.

  41. Butler AE et al. Marked Expansion of Exocrine and Endocrine Pancreas with Incretin Therapy in Humans with increased Exocrine Pancreas Dysplasia and the potential for Glucagon-producing Neuroendocrine Tumors. Diabetes 013 March 22, doi: 10.2337/db12-1686

  42. Brodovicz KG et al. Glucagon-like Peptide 1–Based Drugs and Pancreatic Safety. JAMA Intern Med.2013;173(19):1842-1843.

  43. Gier B, Butler PC. Glucagonlike Peptide 1–Based Drugs and Pancreatitis: Clarity at Last, but What About Pancreatic Cancer? JAMA Intern Med. 2013;173(7):539-541.

  44. Laczek JT, Shrestha M, Kortan ND, Lake JM. Carbamazepine-induced pancreatitis with positive rechallenge. J Clin Gastroenterol. 2010 Feb;44(2):153-4.

  45. Becker C, Hvalic C, Delmore G, Krähenbühl S, Schlienger R. Recurrent acute pancreatitis during pravastatin-therapy. Praxis (Bern 1994). 2006 Jan 25;95(4):111-6.

  46. Johnson JL, Loomis IB. A case of simvastatin-associated pancreatitis and review of statin-associated pancreatitis. Pharmacotherapy. 2006 Mar;26(3):414-22.

  47. Singh S, Loke YK. Statins and pancreatitis: a systematic review of observational studies and spontaneous case reports. Drug Saf. 2006;29(12):1123-32.

  48. Tsigrelis C, Pitchumoni CS. Pravastatin: a potential cause for acute pancreatitis. World J Gastroenterol. 2006 Nov 21;12(43):7055-7.

  49. Bai HX et al. Novel characterization of drug-associated pancreatitis in children. J Pediatr Gastroenterol Nutr. 2011 Oct;53(4):423-8.

  50. Sinclair DB, Berg M, Breault R. Valproic acid-induced pancreatitis in childhood epilepsy: case series and review. J Child Neurol. 2004 Jul;19(7):498-502.

  51. Ozaydin E, Yükselgüngör H, Köse G. Acute hemorrhagic pancreatitis due to the use of valproic acid in a child. Eur J Paediatr Neurol. 2008 Mar;12(2):141-3.

  52. Munhoz RP, dos Santos ML, Hernández-Fustes OJ. Fatal necro-hemorrhagic pancreatitis related to sodium valproate: case report. Arq Neuropsiquiatr. 2001 Sep;59(3-B):821-3.

  53. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008 Feb;51(2):216-26.

  54. Dawud FA et al. Ameliorative Effects of Vitamin C and Zinc in Alloxan-induced Diabetes and Oxidative Stress in Wistar Rats. Curr Res Biolo Sc 2012; 4(2): 123-129.

Gerelateerde artikelen

De pancreas
Voeding voor het brein
Beweging even goed als farmaca
Farmaceutische antidepressiva
Pijnstillers in medicatie en voeding